Beijing Succeeder Technology Inc.

Gwaro rechina rakakosha rekubvumirana, rinotungamirwa neThrombosis and Hemostasis Committee yeChinese Association of Research Hospitals, raburitswa.

"Kubvumirana kweNyanzvi paKutarisa Mishonga Yakafanana neHeparin" kwakagadzirwa pamwe chete neThrombosis and Hemostasis Committee yeChinese Association of Research Hospitals neLaboratory Science Branch yeChinese Geriatrics Society. Gwaro iri, rakanyorwa pamwe chete nenyanzvi dzedzidzo dzakasiyana-siyana kubva kuChina yese, rakatora makore maviri kuti rigadzirwe, mushure mekukurukurirana kwakawanda uye kugadziriswa. Chinyorwa chekupedzisira chakazobvumiranwa uye chakaburitswa muna Nyamavhuvhu 2025 muChinese Journal of Laboratory Medicine, Vhoriyamu 48, Chinyorwa 8.

Kubvumirana uku kunopa gwara rakajairika rekutarisa mishonga yakaita seheparin murabhoritari, zvichipa rutsigiro rwakavimbika rwerabhoritari rwekuti kurapwa kwekurapa kwekudzivirira ropa kuitwe zvakachengeteka uye zvinobudirira. Pakupedzisira, zvichabatsira varwere vakasiyana-siyana uye zvichaita kuti kurapwa kwe heparin kudzivirire ropa kuitwe kwakarongeka uye kwakarurama.

PFUNGWA

Mishonga yakaita seheparin inowanzo shandiswa semushonga unorwisa ropa kudzivirira nekurapa zvirwere zve thromboembolic. Kushandiswa kwakakodzera uye kutarisa kwakakodzera kwemishonga iyi kwakakosha pakuona kuchengetedzeka nekushanda kwekurapa. Kubvumirana uku kwenyanzvi kunobva mumabhuku akakodzera emuno neepasi rose, vachifunga zvizere nezvemamiriro aripo iye zvino uye kufambira mberi kwekushandiswa kweheparin. Yakaunganidza boka renyanzvi mumunda wekudzivirira ropa, kusanganisira nyanzvi dzemurabhoritari nedzekiriniki, kuti vakurukure zviratidzo, chiyero, uye kutarisa heparin. Kunyanya, yakajekesa mashandisirwo ekiriniki ezviratidzo zvemurabhoritari zvakaita se anti-Xa activity uye yakagadzira mazano enyanzvi nechinangwa chekusimudzira kushandiswa kwakachengeteka uye kunobudirira kweheparin uye kugadzirisa kutarisa kwemurabhoritari.Chinyorwa chino chakadhindwazve kubva ku: Thrombosis and Hemostasis (CSTH).

Beijing Succeeder Technology Inc. (kodhi yemasheya: 688338) yave ichibatanidzwa zvakanyanya mubazi rekuongorora ropa kubva payakatangwa muna 2003, uye yakazvipira kuva mutungamiri mubazi iri. Iri muBeijing, kambani iyi ine timu yakasimba yeR&D, yekugadzira nekutengesa, inotarisa pakuvandudza nekushandisa tekinoroji yekuongorora ropa neropa.

Nesimba rayo guru rehunyanzvi, Succeeder yakahwina mapatents makumi mana nemashanu ane mvumo, anosanganisira mapatents gumi nemana ekugadzira zvinhu zvitsva, mapatents gumi nematanhatu emhando yemagetsi uye mapatents ekugadzira gumi nemashanu. Kambani iyi inewo zvitupa zvekunyoresa zvigadzirwa zvemhando yechipiri zvemhando yechitatu, zvitupa zvitatu zvefaira zvemhando yekutanga, uye chitupa cheEU CE chezvigadzirwa gumi nemana, uye yakapasa chitupa cheISO 13485 chehunhu hwekutarisira mhando kuti ive nechokwadi chekuti mhando yechigadzirwa yakanaka uye yakagadzikana.

Succeeder haisi kambani huru yeBeijing Biomedicine Industry Leapfrog Development Project (G20) chete, asi yakabudirirawo kupinda muScience and Technology Innovation Board muna 2020, zvichiita kuti kambani ibudirire zvikuru. Parizvino, kambani iyi yakavaka network yekutengesa munyika yese inobatanidza mazana evamiririri nemahofisi. Zvigadzirwa zvayo zvinotengeswa zvakanaka munzvimbo zhinji dzenyika. Iri kuwedzerawo misika yekune dzimwe nyika uye iri kuramba ichivandudza kukwikwidza kwayo pasi rose.